Investing
Proceeds from Sale of Seagen Inc. Common Stock
Allstate Proceeds from Sale of Seagen Inc. Common Stock increased by 274.4% to $4.06B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 188.0%, from $1.41B to $4.06B. Over 4 years (FY 2021 to FY 2025), Proceeds from Sale of Seagen Inc. Common Stock shows an upward trend with a 10.5% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2019
Last reportedQ1 2026Apr 29, 2026
Metric ID:
mrk_proceeds_from_sale_of_seagen_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $875.00M | $1.28B | $1.36B | $5.22B | $2.41B | $1.15B | $2.20B | $3.74B | $444.00M | $572.00M | $645.00M | $500.00M | $1.01B | $627.00M | $1.03B | $1.41B | $3.20B | $1.04B | $1.08B | $4.06B |
| QoQ Change | — | +46.7% | +6.1% | +283.0% | -53.9% | -52.4% | +92.3% | +69.8% | -88.1% | +28.8% | +12.8% | -22.5% | +102.0% | -37.9% | +64.4% | +36.6% | +127.3% | -67.6% | +4.3% | +274.4% |
| YoY Change | — | — | — | — | +175.0% | -10.8% | +61.7% | -28.3% | -81.5% | -50.0% | -70.7% | -86.6% | +127.5% | +9.6% | +59.8% | +181.6% | +216.8% | +65.6% | +5.0% | +188.0% |
Range$444.00M – $5.22B
CAGR+38.1%
Avg YoY Growth+47.7%
Median YoY Growth+34.7%
Current Streak2 quarters growth
Proceeds from Sale of Seagen Inc. Common Stock at Other Companies
Frequently Asked Questions
- What is Allstate's proceeds from sale of seagen inc. common stock?
- Allstate (ALL) reported proceeds from sale of seagen inc. common stock of $4.06B in Q1 2026.
- How has Allstate's proceeds from sale of seagen inc. common stock changed year-over-year?
- Allstate's proceeds from sale of seagen inc. common stock increased by 188.0% year-over-year, from $1.41B to $4.06B.
- What is the long-term trend for Allstate's proceeds from sale of seagen inc. common stock?
- Over 4 years (2021 to 2025), Allstate's proceeds from sale of seagen inc. common stock has grown at a 10.5% compound annual growth rate (CAGR), from $4.51B to $6.73B.